HomeStrategyA $435 Million Bet on ‘Reversing Aging’ Strategy A $435 Million Bet on ‘Reversing Aging’ Strategy June 7, 2026 0 159 FacebookXPinterestWhatsApp Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver. FacebookXPinterestWhatsApp Cody Previous articleDell sharpens data protection strategy as AI reshapes cyber resilienceNext articleLayoffs don’t have to feel inhumane RELATED ARTICLES Strategy Still Using LinkedIn? A Stanford Study of 29,448,462 Profiles Explains What’s Changed Strategy Taco Bell is bringing back 4 discontinued favorite menu items, including one fans begged for Strategy How the ‘mommy track’ derails working women—and it’s only gotten worse Strategy Disney just sued the Trump administration over an ‘unprecedented’ move against ABC Must Read Still Using LinkedIn? A Stanford Study of 29,448,462 Profiles Explains What’s Changed Strategy Healthcare software firm Weave Communications to go private after being acquired by Francisco Partners Tech OpenAI’s junior version of ChatGPT with guardrails has launched Tech OpenAI falls further behind Anthropic, with disappointing revenue growth and mounting losses Tech Cybersecurity concerns prompt OpenAI to pause some AI training runs Tech